|
2025
|
Invention
|
Fusion protein comprising il-2 protein and cd80 protein, and use thereof.
Provided is a fusion p... |
|
2024
|
Invention
|
Fusion protein comprising cd80 protein and il-2 protein, and composition for preventing or treati... |
|
|
Invention
|
Novel cancer therapeutic agent comprising anticancer dna vaccine and immune response-enhancing fu... |
|
|
Invention
|
Fusion protein comprising anti-cd73 antibody and il-2, and use thereof.
A fusion protein in whic... |
|
2023
|
Invention
|
Antibody specifically binding to cd73 and use thereof. The present invention relates to an antibo... |
|
|
Invention
|
Pharmaceutical composition for cancer treatment comprising fusion protein including il-2 protein ... |
|
|
Invention
|
Combined therapy of lactobacillus plantarum strain, and cancer treatment method using same. The p... |
|
|
Invention
|
Fusion protein comprising anti-cd73 antibody and il-2, and use thereof. The present invention rel... |
|
|
Invention
|
Bispecific antibody including anti-tigit antibody, and use thereof. The present invention relates... |
|
|
Invention
|
Pharmaceutical composition for treatment of cancer, comprising an immune checkpoint inhibitor ant... |
|
|
Invention
|
Pharmaceutical composition for preventing or treating degenerative brain diseases, containing glu... |
|
2022
|
Invention
|
Fusion protein comprising cd80 extracellular domain and anti-lag3 antibody fragment and use there... |
|
|
Invention
|
Fusion protein comprising il-2 protein and cd80 protein, and use thereof. Provided is a fusion pr... |
|
|
Invention
|
Formulation of fusion protein including extracellular domain of alpha subunit of ige fc receptor.... |
|
2021
|
Invention
|
Fusion protein including ige fc receptor and use thereof for treatment of canine allergic disease... |
|
|
Invention
|
Fusion protein comprising ige fc receptor alpha subunit extracellular domain and anti-il-4r antib... |
|
|
Invention
|
Fusion protein including glucagon-like peptide-1 and glucagon-like peptide-2 and use thereof. The... |
|
|
Invention
|
Fusion protein including glucagon-like peptide-1 and interleukin-1 receptor antagonist and use th... |
|
|
Invention
|
Fusion protein comprising anti-lag-3 antibody and il-2, and use thereof.
The present invention r... |
|
|
Invention
|
Fusion protein comprising anti-lag-3 antibody and il-2, and use thereof. The present invention re... |
|
|
Invention
|
Pharmaceutical composition for enhancing radiotherapy comprising fusion protein containing il-2 p... |
|
|
Invention
|
Fusion protein comprising il-2 protein and cd80 protein fragment or variant thereof, and uses the... |
|
|
Invention
|
Fusion protein preparation comprising il-2 and cd80 proteins.
The present invention relates to a... |
|
|
Invention
|
Fusion protein preparation comprising il-2 and cd80 proteins. The present invention relates to a ... |
|
2020
|
Invention
|
Pharmaceutical composition for treatment of cancer, comprising immune checkpoint inhibitor and fu... |
|
|
Invention
|
Pharmaceutical composition for treating cancer comprising fusion protein comprising il-2 protein ... |
|
|
Invention
|
Polypeptide dimer with high sialic acid content, comprising extracellular domain of alpha subunit... |
|
2019
|
Invention
|
Fusion protein comprising il-2 protein and cd80 protein, and use thereof. The present invention p... |
|
|
Invention
|
Fusion protein comprising il-2 protein and cd80 protein, and use thereof.
The pre... |
|
|
Invention
|
Polypeptide dimer containing high amount of sialic acid and including extracellular domain of alp... |
|
|
Invention
|
Composition comprising probiotics and polypeptide having binding affinity for ige and use thereof... |
|
|
Invention
|
Extracellular domain of alpha subunit of ige fc receptor, pharmaceutical composition comprising s... |
